InfuSystem Holdings, a leading national provider of infusion pumps and related services for the healthcare industry in the US and Canada, announced that its subsidiary, InfuSystem Inc., has reached an agreement for the acquisition of the infusion pump assets of InfusAID, LLC.
InfusAID, based in the Philadelphia area, is a privately-held regional provider of ambulatory infusion pumps and services to medical facilities. InfuSystem will acquire approximately 400 infusion pumps from InfusAID pursuant to the agreement.
"Similar to our acquisition of Ciscura in 2015, the pumps we acquire from InfusAID will come to us with 18 medical facility relationships that will help us gain additional market share as the marketplace continues to consolidate.
"We also believe this transaction will offer clinicians and patients better access to more affordable in-network care via InfuSystem’s 340+ insurance payor contracts," said Eric K. Steen, chief executive officer of InfuSystem.
Mr. Steen continued, "To the customer facilities formerly served by InfusAID, we will offer our expanded portfolio that includes our patent-pending, time-saving electronic connectivity solutions, pole-mounted infusion pumps, infusion-related disposables such as catheter care kits and IV tubing, and chemo safety products that meet the proposed USP Chapter 800 requirements. We believe this will further help these facilities deliver the highest quality care to their patients."
InfuSystem Holdings, Inc. is a leading provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers.
Headquartered in Madison Heights, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Texas, Georgia and Ontario, Canada. The Company’s stock is traded on the NYSE MKT under the symbol INFU.